New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

RSPHvsIYHETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.07%
VS
ETF 2
IYH

iShares U.S. Healthcare ETF

This fund is part of
US Health Care
+0.07%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and iShares U.S. Healthcare ETF (IYH) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IYH's top sector exposures are Healthcare, Non-Corporate and Finance. RSPH is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.37% for IYH. RSPH is up 16.48% year-to-date (YTD) with +$57M in YTD flows. IYH performs worse with 10.56% YTD performance, and -$47M in YTD flows. Run a side-by-side ETF comparison of RSPH and IYH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs IYH performance and flow charts

Performance

0.02.04.06.0%Aug 17Aug 24Aug 31Sep 8Sep 15

Cumulative Flows

-100 M-50 M0 M50 M100 MAug 17Aug 24Aug 31Sep 8Sep 15

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/17/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
IYH
+3.25%+1.36%
+17.65%+13.35%
+16.48%+10.56%
+28.50%+25.11%
+34.15%+33.91%
+22.20%+31.80%
Flows
RSPH
IYH
+$104M+$108M
+$100M+$342M
+$57M-$47M
+$38M+$395M
-$257M-$139M
-$266M-$15M
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
IYH
+20.51%+19.20%
+16.75%+16.28%
+15.89%+14.98%
+16.80%+15.45%
Max drawdown
RSPH
IYH
-5.57%-5.88%
-10.87%-10.72%
-16.96%-17.89%
-21.91%-17.89%
Max drawdown duration
RSPH
IYH
29d29d
116d169d
434d445d
817d445d
Trading data

Create an account to view trading data

Join for free
RSPH
IYH
Last sale
9/17/2026 at 1:30 PM
$36.97
$71.37
Previous close
09/17/2026
$36.78
$70.77
Consolidated volume
09/17/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
RSPH
IYH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/17/2026 at 1:30 PM
Live
Closed
RSPH
IYH
Last price
$36.97
$71.37
1D performance
+0.52%
+0.85%
AuM$913.92 M$3.84 B
E/R0.4%0.37%
Characteristics
RSPH
IYH
Management strategyPassivePassive
ProviderInvescoiShares
BenchmarkS&P 500 Equal Weight Health Care IndexRussell 1000 Health Care RIC 22.5/45 Capped Gross Index
N° of holdings59101
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006June 12, 2000
ESGNoNo
Advertisement
Exposure

Countries

RSPH
USA
96.6%
Other
3.4%
IYH
USA
96.84%
Other
3.16%

Sectors

RSPH
Healthcare
98.34%
Other
1.66%
IYH
Healthcare
99.75%
Other
0.25%
Advertisement

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%
IYH

Total weight of top 15 holdings out of 15

69.24%

Top 15 holdings

Data as of July 31, 2026
RSPH
Bio-Techne Corp.
2.10%
IQVIA Holdings, Inc.
2.08%
Veeva Systems, Inc.
1.95%
Charles River Laboratories International, Inc.
1.93%
Mettler-Toledo International, Inc.
1.89%
Baxter International, Inc.
1.87%
DaVita, Inc.
1.86%
Abbott Laboratories
1.86%
Incyte Corp.
1.85%
Thermo Fisher Scientific, Inc.
1.83%
Moderna, Inc.
1.82%
AbbVie, Inc.
1.79%
Universal Health Services, Inc.
1.78%
Regeneron Pharmaceuticals, Inc.
1.77%
Quest Diagnostics, Inc.
1.77%
IYH
Eli Lilly & Co.
15.09%
Johnson & Johnson
10.09%
AbbVie, Inc.
7.46%
UnitedHealth Group, Inc.
6.23%
Merck & Co., Inc.
5.25%
Thermo Fisher Scientific, Inc.
3.51%
Amgen, Inc.
3.42%
Abbott Laboratories
2.99%
Gilead Sciences, Inc.
2.67%
Pfizer Inc.
2.32%
Bristol Myers Squibb Co.
2.17%
Intuitive Surgical, Inc.
2.04%
Danaher Corp.
2.03%
Vertex Pharmaceuticals, Inc.
2.00%
Stryker Corp.
1.97%
Frequently asked questions about RSPH and IYH

How have the RSPH and IYH ETFs performed in 2026?

As of September 17, 2026, RSPH is up 16.48% year-to-date (YTD), while IYH has returned 10.56%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or IYH?

Year-to-date, the RSPH ETF saw +$57M in flows, compared to -$47M for IYH.

Which ETF is more volatile: RSPH or IYH?

Over the past year, RSPH had a volatility of 16.75%, while IYH experienced 16.28%.

Which ETF is bigger: RSPH or IYH?

As of September 17, 2026, RSPH holds $913.92 M in assets under management (AUM), while IYH manages $3.84 B.

What sectors do the RSPH and IYH ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, IYH focuses on Healthcare.

What are the top holdings of the RSPH ETF and IYH ETF?

RSPH top holdings include Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc.. IYH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: RSPH or IYH?

RSPH holds 59 securities with 28.14% of its assets in the top 15. IYH has 101 securities and a top 15 weight of 69.24%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder